Cardiovascular disease (CVD) is the leading cause of death in Western countries,
representing almost 30% of all deaths worldwide. Evidence shows the effectiveness of …

Background The coronavirus disease 2019 (COVID-19) is a pandemic caused by
coronavirus with mild to severe respiratory symptoms. This paper aimed to investigate the …

Vitamin E, comprising tocopherols and tocotrienols, is mainly known as an antioxidant. The
aim of this review is to summarize the molecular mechanisms and signaling pathways linked …

Vitamin E (α-tocopherol) is recognised as a key essential lipophilic antioxidant in humans
protecting lipoproteins, PUFA, cellular and intra-cellular membranes from damage. The aim …

Metabolic syndrome (MetS) is established as the combination of central obesity and different
metabolic disturbances, such as insulin resistance, hypertension and dyslipidemia. This …

The current research was performed to evaluate the effects of omega-3 fatty acids and
vitamin E co-supplementation on clinical signs and metabolic status in people with …

The new coronavirus disease 2019 (COVID-19) pandemic is an emerging situation with high
rates of morbidity and mortality, in the pathophysiology of which inflammation and …

Atherosclerosis is a chronic low-grade inflammatory disease that affects large and medium-
sized arteries and is considered to be a major underlying cause of cardiovascular disease …

The previous meta-analysis of clinical trials revealed a beneficial effect of vitamin E
supplementation on serum C-reactive protein (CRP) concentrations; however, it is unknown …

Background & aims The European Society for Clinical Nutrition and Metabolism published
its first clinical guidelines for use of micronutrient (MNs) in 2022. A two-day web symposium …